Product image of Miramel (Pramipexole) supplied by GNH India

Miramel

Active Ingredient:
Pramipexole
Origin:
EU

Miramel (Pramipexole)

Pramipexole, the active ingredient in Miramel, is a dopamine agonist presented as a tablet for oral use. It stimulates dopaminergic activity in the brain and is used to manage symptoms of Parkinson's disease and restless legs syndrome in adult patients.

GNH India supplies Miramel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. This includes compliance with EU GMP guidelines and comprehensive documentation for import.

Manufacturer / TM Owner

Clonmel Healthcare Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pramipexole is a dopamine agonist used in the management of movement disorders.

  • Parkinson's disease: helps control motor symptoms including bradykinesia, rigidity, tremor and improves overall functional mobility in patients with early to advanced stages.
  • Restless legs syndrome: diminishes uncomfortable sensations and the urge to move the legs, leading to better sleep continuity and reduced daytime fatigue in affected individuals.
  • Adjunct therapy in Parkinson's disease: used alongside levodopa to lessen motor fluctuations and "off" periods, enhancing overall symptom control.

How It Works

  • Pramipexole acts as a selective agonist at dopamine D2 and D3 receptors in the central nervous system. By binding to these receptors, it mimics dopamine activity, enhancing dopaminergic neurotransmission in basal ganglia circuits that regulate movement. This stimulation compensates for the dopamine deficiency characteristic of Parkinsonian disorders and modulates sensory pathways involved in restless legs syndrome, thereby improving motor function and reducing uncomfortable sensations.

Side Effects

Pramipexole may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea
  • Dizziness
  • Somnolence
  • Headache
  • Constipation
  • Fatigue

Serious or Rare Side Effects

  • Hallucinations
  • Impulse control disorders (e.g., compulsive gambling, shopping)
  • Orthostatic hypotension
  • Severe skin reactions
  • Suicidal thoughts or behaviors

Precautions & Warnings

When prescribing pramipexole, clinicians should consider several precautionary measures to ensure safe use.

  • Renal impairment: adjust dose based on renal function assessment.
  • Psychiatric history: monitor for hallucinations, confusion or mood changes.
  • Cardiovascular disease: observe for orthostatic hypotension and syncope.
  • Elderly patients: start with low dose and titrate slowly due to increased sensitivity.
  • Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited.
  • Store below 25°C: keep in the original packaging, protect from moisture and light.

Avoid Interactions

Pramipexole can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Antipsychotics (e.g., haloperidol, risperidone): may antagonize dopaminergic effects, reducing therapeutic benefit.
  • MAO‑B inhibitors (e.g., selegiline): can increase dopaminergic activity and risk of hypertensive reactions.

Moderate Interactions (Monitor Closely)

  • CNS depressants (e.g., alcohol, benzodiazepines): may enhance sedation and dizziness.
  • Antihypertensive agents: additive effect on blood pressure, monitor for hypotension.
  • Metoclopramide: may counteract pramipexole’s action and increase side effects.

Frequently Asked Questions

Miramel contains pramipexole, which is prescribed to treat motor symptoms of Parkinson's disease and to relieve the uncomfortable sensations and urge to move the legs that characterize restless legs syndrome. It may also be used as an adjunct to levodopa therapy to reduce motor fluctuations.

Pramipexole works by selectively stimulating dopamine D2 and D3 receptors in the brain. This mimics the action of dopamine, enhancing neurotransmission in pathways that control movement and sensory perception, thereby compensating for the dopamine deficiency seen in Parkinsonian disorders and restless legs syndrome.

The specific dose of Miramel is determined by the prescribing clinician based on the individual’s condition, age, renal function and response to therapy. The prescriber will start with a low dose and adjust gradually to achieve the desired clinical effect while monitoring for tolerability.

Safety data for pramipexole in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Miramel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

The primary alternative to pramipexole is ropinirole, another dopamine agonist, and levodopa, the cornerstone of Parkinson's therapy. Pramipexole often offers a longer half‑life and may cause fewer motor complications than levodopa, while ropinirole has a similar efficacy profile but different side‑effect tendencies.

Miramel tablets should be stored at temperatures below 25 °C, in the original container, protected from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Miramel is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include the development of hallucinations, impulse‑control disorders such as compulsive gambling or shopping, and severe orthostatic hypotension that can lead to falls. Patients should report any unusual thoughts, behaviors or sudden drops in blood pressure to their doctor promptly.

Miramel is contraindicated in patients with known hypersensitivity to pramipexole or any excipients in the tablet. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric illness, or those taking medications that strongly antagonize dopamine receptors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pramipexole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT